Minimally Invasive Surgery in Gastrointestinal Disease: Current Status and Future Directions

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "General Surgery".

Deadline for manuscript submissions: closed (25 April 2024) | Viewed by 654

Special Issue Editors


E-Mail
Guest Editor
General and Liver Transplant Surgery, The Gemelli University Hospital, Rome, Italy
Interests: liver transplant; liver diseases; HPB surgery; pancreatic surgery; minimally invasive surgery; surgical oncology
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Department of General Surgery, Ospedale Del Mare Hospital, Via Enrico Russo, 80147 Naples, Italy
Interests: hepatobiliary–pancreatic surgery and cancers; abdominal surgical oncology; liver and pancreatic benign and chronic diseases; emergency abdominal surgery

Special Issue Information

Dear Colleagues,

Minimally invasive surgery (MIS) plays a crucial role in the management of gastrointestinal (GI) diseases, revolutionizing the field of surgical intervention. This advanced technique utilizes small incisions and specialized instruments to access the affected area, reducing trauma and enhancing patient outcomes.

In the context of GI diseases, MIS offers numerous advantages. It leads to less postoperative pain, shorter hospital stays and faster recovery times compared to traditional open surgeries. Patients experience an improved quality of life and can resume their daily activities sooner.

Moreover, MIS provides enhanced visualization and precision during GI procedures, such as hernia repairs, gallbladder removals and appendectomies. This results in reduced complications and faster healing.

The role of MIS in GI disease management continues to expand as technology evolves, providing patients with less invasive treatment options, better outcomes and an overall improved experience.

Dr. Alessandro Coppola
Dr. Giuseppe Bianco
Dr. Andrea Tufo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • minimally invasive surgery
  • laparoscopic
  • robotic
  • new technologies
  • gastrointestinal surgery
  • HPB surgery
  • surgical oncology

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

13 pages, 681 KiB  
Systematic Review
Pancreatic Neuroendocrine Tumors: What Is the Best Surgical Option?
by Renato Patrone, Federico Maria Mongardini, Alessandra Conzo, Chiara Cacciatore, Giovanni Cozzolino, Antonio Catauro, Eduardo Lanza, Francesco Izzo, Andrea Belli, Raffaele Palaia, Luigi Flagiello, Ferdinando De Vita, Ludovico Docimo and Giovanni Conzo
J. Clin. Med. 2024, 13(10), 3015; https://doi.org/10.3390/jcm13103015 - 20 May 2024
Viewed by 420
Abstract
Background: Pancreatic neuroendocrine tumors (pNETs) represent a rare subset of pancreatic cancer. Functional tumors cause hormonal changes and clinical syndromes, while non-functional ones are often diagnosed late. Surgical management needs multidisciplinary planning, involving enucleation, distal pancreatectomy with or without spleen preservation, central [...] Read more.
Background: Pancreatic neuroendocrine tumors (pNETs) represent a rare subset of pancreatic cancer. Functional tumors cause hormonal changes and clinical syndromes, while non-functional ones are often diagnosed late. Surgical management needs multidisciplinary planning, involving enucleation, distal pancreatectomy with or without spleen preservation, central pancreatectomy, pancreaticoduodenectomy or total pancreatectomy. Minimally invasive approaches have increased in the last decade compared to the open technique. The aim of this study was to analyze the current diagnostic and surgical trends for pNETs, to identify better interventions and their outcomes. Methods: The study adhered to the PRISMA guidelines, conducting a systematic review of the literature from May 2008 to March 2022 across multiple databases. Several combinations of keywords were used (“NET”, “pancreatic”, “surgery”, “laparoscopic”, “minimally invasive”, “robotic”, “enucleation”, “parenchyma sparing”) and relevant article references were manually checked. The manuscript quality was evaluated. Results: The study screened 3867 manuscripts and twelve studies were selected, primarily from Italy, the United States, and China. A total of 7767 surgically treated patients were collected from 160 included centers. The mean age was 56.3 y.o. Enucleation (EN) and distal pancreatectomy (DP) were the most commonly performed surgeries and represented 43.4% and 38.6% of the total interventions, respectively. Pancreatic fistulae, postoperative bleeding, re-operation, and follow-up were recorded and analyzed. Conclusions: Enucleation shows better postoperative outcomes and lower mortality rates compared to pancreaticoduodenectomy (PD) or distal pancreatectomy (DP), despite the similar risks of postoperative pancreatic fistulae (POPF). DP is preferred over enucleation for the pancreas body–tail, while laparoscopic enucleation is better for head pNETs. Full article
Show Figures

Figure 1

Back to TopTop